BMAC Doesn't Work for Everyone. That's Exactly the Point, Says Franklin, TN Orthopedic Surgeon Dr. Ethan Kellum.

Nov 21, 2026

Franklin, TN, United States, November 21, 2026 -- With growing patient interest in bone marrow aspirate concentrate for joint conditions, Dr. Ethan Kellum Regenerative Solutions is addressing a question the science already answers: BMAC's value depends on who receives it, not just what it does.


Franklin, TN, November 3, 2026: Dr. Ethan Kellum, MD/MS, a fellowship-trained orthopedic surgeon and regenerative medicine specialist practicing in Franklin, Tennessee, is speaking directly to patients who've heard conflicting things about bone marrow aspirate concentrate (BMAC) and aren't sure what to believe. His position is straightforward: BMAC produces real clinical results for the right patients, and it falls short when applied without proper candidacy evaluation. That distinction isn't a marketing claim. It's a description of how orthobiologic medicine behaves in the body.


"What I want patients to understand is that BMAC not working universally isn't a weakness of the therapy," said Dr. Kellum. "It's a description of biology. The concentrate delivers growth factors, cytokines, and progenitor cells drawn from a patient's own bone marrow. What it does in the joint depends on the tissue it encounters, the severity of the condition, the patient's age and biologic profile, and the vascularity of the target structure. A partial-thickness rotator cuff tear in a 40-year-old is a different problem than advanced knee osteoarthritis in a 65-year-old, and BMAC responds to them accordingly. Treating those as equivalent candidates is where outcomes go wrong."


Why Candidacy Comes Before Treatment
Dr. Kellum has treated more than 10,000 patients since beginning practice in 2005 and established his regenerative medicine practice in Tennessee in 2017. He holds fellowship training from New England Baptist Hospital and Boston Children's Hospital, trained in orthopedic surgery at the Medical College of Georgia, and earned his medical degree from the University of Tennessee Health Science Center. He serves as team physician for the Tennessee Titans and USA Basketball and previously worked with the Boston Celtics. He is a member of the Alpha Omega Alpha medical honor society and an author of peer-reviewed medical publications.


That depth of background shapes how the practice evaluates patients. Before any treatment is recommended, Dr. Kellum conducts a thorough orthopedic assessment. The evaluation considers the specific diagnosis, how far the condition has progressed, what treatments have already been tried, and whether the patient's anatomy and biology make them a reasonable candidate for a regenerative approach. Surgery stays on the table throughout that conversation. Dr. Kellum continues to perform arthroscopic procedures of the shoulder and knee. The model is built around finding the right answer, not defaulting to any single path.


Consider a patient who comes in after months of knee pain, having been told surgery is likely the next step. Depending on the presentation, a candidacy evaluation might confirm that. It might also identify a condition that responds well to BMAC or PRP, or one that benefits from surgery combined with orthobiologics. The consultation exists to sort through those possibilities with clinical precision. What it doesn't do is start with a predetermined recommendation and work backward.


What BMAC Actually Does in the Joint
BMAC is drawn from the patient's own bone marrow, typically from the iliac crest. The concentrate is processed to increase the density of growth factors, cytokines, and progenitor cells, then injected into the target area. In tissue with adequate vascularity and a condition that hasn't progressed beyond a point of reasonable biological response, those biologics modulate inflammation and support local repair processes. That mechanism is real, documented, and clinically meaningful in appropriate candidates.


It's also not universal. Grade IV cartilage loss, advanced joint destruction, or conditions with compromised local blood supply present a different biological environment. BMAC interacts with that environment differently, and honest evaluation has to account for it. Patients who've been told BMAC is a blanket surgery replacement deserve to know the clinical picture is more specific than that. Patients who've been told surgery is their only option deserve to know that for certain diagnoses, a well-indicated BMAC procedure has genuine clinical support behind it.


The practice also offers PRP, adipose-derived treatments, prolotherapy, and other orthobiologics. Dr. Kellum is among the early adopters of advanced regenerative treatments in Tennessee and is currently expanding treatment capabilities with Dezawa Muse Cell therapy.


Who Should Have This Conversation
Patients throughout Nashville, Franklin, Brentwood, and Cool Springs exploring BMAC for knee pain, hip or shoulder degeneration, a sports injury, a spinal condition, or chronic joint problems have access to the kind of evaluation that actually determines whether the therapy fits their situation. Patients also travel from across Tennessee and from other states to consult with Dr. Kellum specifically because of his combined background in orthopedic surgery and regenerative medicine.


Waiting to explore options isn't a neutral choice. Joint conditions don't tend to simplify over time, and some biological windows for regenerative treatment narrow as degeneration progresses. A consultation at Dr. Ethan Kellum Regenerative Solutions doesn't commit anyone to a procedure. It's the beginning of an informed conversation about what's actually happening in the joint and what the realistic options are for that specific patient.


About Dr. Ethan Kellum Regenerative Solutions
Dr. Ethan Kellum Regenerative Solutions is a fellowship-trained orthopedic and regenerative medicine practice based in Franklin, Tennessee, serving patients throughout the Nashville, Brentwood, and Cool Springs areas. Founded in 2017 by Dr. Ethan Kellum, MD/MS, the practice helps patients with joint pain, arthritis, and orthopedic injuries evaluate the full range of treatment options, including BMAC, PRP, orthobiologics, and surgery when clinically indicated. Dr. Kellum serves as team physician for the Tennessee Titans and USA Basketball, holds fellowship training from New England Baptist Hospital and Boston Children's Hospital, and is a member of the Alpha Omega Alpha medical honor society.

Contact Info:
Name: Dr. Ethan Kellum
Email: Send Email
Organization: Dr. Ethan Kellum Regenerative Solutions
Phone: +1 615 850 4415
Website: https://drethankellum.com

Release ID: 89210396

If you come across any problems, discrepancies, or concerns related to the content contained within this press release that necessitate action or if a press release requires takedown, we strongly encourage you to reach out without delay by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will be readily accessible round-the-clock to address your concerns within 8 hours and take appropriate actions to rectify identified issues or support with press release removals. Ensuring accurate and reliable information remains our unwavering commitment.

More News

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Central News Today

Central News Today breaks down complex issues with unique perspective, bringing high-quality journalism to millions of readers around the world.

NEWSLETTER